Drug intelligence / Profile preview

gold nanoparticle from pelargonium graveolens

Development stage: Unknown
Lead developer: Ahmed Yousif Mahdi
Modality: Nanoparticles → Drug Delivery Systems
Administration: Topical

Overview

Biogenic gold nanoparticles synthesized using *Pelargonium graveolens* (rose geranium) leaf extract. This formulation is developed as an antimicrobial mouthwash for pediatric use, specifically targeting oral pathogens associated with gingivitis and dental caries. The synthesis involves using the plant's phytochemicals as reducing and stabilizing agents to create gold nanoparticles (AuNPs). The resulting GNPG mouthwash is being evaluated for its efficacy against *Streptococcus mutans* and *Candida albicans* compared to standard treatments like chlorhexidine.

Other names: biogenic gold nanoparticles from Pelargonium graveolensPelargonium graveolens gold nanoparticlesGNPG mouthwash

Beyond the preview

Go deeper on gold nanoparticle from pelargonium graveolens.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on gold nanoparticle from pelargonium graveolens.

Explore the full profile